nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—Abdominal discomfort—Tretinoin—peripheral nervous system neoplasm	0.0173	0.0173	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.0173	0.0173	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.0131	0.0131	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Topotecan—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Tretinoin—peripheral nervous system neoplasm	0.0126	0.0126	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Isotretinoin—peripheral nervous system neoplasm	0.0126	0.0126	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Isotretinoin—peripheral nervous system neoplasm	0.0124	0.0124	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Tretinoin—peripheral nervous system neoplasm	0.0124	0.0124	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.0112	0.0112	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.0101	0.0101	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.0101	0.0101	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.0101	0.0101	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.00952	0.00952	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.00938	0.00938	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.0091	0.0091	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00902	0.00902	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00902	0.00902	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00898	0.00898	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00892	0.00892	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00891	0.00891	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00891	0.00891	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00891	0.00891	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00891	0.00891	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00885	0.00885	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00885	0.00885	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00884	0.00884	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00884	0.00884	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00879	0.00879	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00873	0.00873	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00872	0.00872	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00845	0.00845	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00838	0.00838	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00838	0.00838	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00817	0.00817	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.00811	0.00811	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.0081	0.0081	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.0081	0.0081	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00799	0.00799	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00762	0.00762	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00741	0.00741	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00735	0.00735	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00735	0.00735	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00734	0.00734	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00728	0.00728	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00726	0.00726	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00722	0.00722	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00707	0.00707	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00701	0.00701	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00701	0.00701	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00692	0.00692	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00685	0.00685	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00684	0.00684	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00683	0.00683	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00678	0.00678	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00678	0.00678	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00675	0.00675	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00671	0.00671	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.0067	0.0067	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00662	0.00662	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00657	0.00657	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00652	0.00652	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00652	0.00652	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Topotecan—peripheral nervous system neoplasm	0.00651	0.00651	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00651	0.00651	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00651	0.00651	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00649	0.00649	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Topotecan—peripheral nervous system neoplasm	0.00647	0.00647	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00646	0.00646	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Tretinoin—peripheral nervous system neoplasm	0.00646	0.00646	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00646	0.00646	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00646	0.00646	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00646	0.00646	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00645	0.00645	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00643	0.00643	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Tretinoin—peripheral nervous system neoplasm	0.00642	0.00642	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00642	0.00642	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Melphalan—peripheral nervous system neoplasm	0.00638	0.00638	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00637	0.00637	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00635	0.00635	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.00632	0.00632	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00614	0.00614	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Topotecan—peripheral nervous system neoplasm	0.00614	0.00614	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00612	0.00612	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00609	0.00609	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00609	0.00609	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00601	0.00601	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Melphalan—peripheral nervous system neoplasm	0.00601	0.00601	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00592	0.00592	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.00584	0.00584	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00575	0.00575	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00573	0.00573	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00571	0.00571	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00557	0.00557	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00537	0.00537	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00533	0.00533	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00531	0.00531	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00528	0.00528	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00527	0.00527	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00523	0.00523	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00523	0.00523	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00514	0.00514	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00512	0.00512	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00498	0.00498	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00496	0.00496	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00495	0.00495	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00494	0.00494	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.0049	0.0049	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00489	0.00489	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00487	0.00487	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00479	0.00479	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00476	0.00476	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00475	0.00475	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Vincristine—peripheral nervous system neoplasm	0.00472	0.00472	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00472	0.00472	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Vincristine—peripheral nervous system neoplasm	0.00469	0.00469	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00461	0.00461	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00453	0.00453	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Vincristine—peripheral nervous system neoplasm	0.00445	0.00445	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00435	0.00435	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00421	0.00421	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Cisplatin—peripheral nervous system neoplasm	0.00417	0.00417	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00417	0.00417	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00416	0.00416	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00415	0.00415	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.0041	0.0041	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00401	0.00401	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00393	0.00393	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00386	0.00386	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00385	0.00385	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Etoposide—peripheral nervous system neoplasm	0.00382	0.00382	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00382	0.00382	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Etoposide—peripheral nervous system neoplasm	0.0038	0.0038	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.0038	0.0038	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Etoposide—peripheral nervous system neoplasm	0.0036	0.0036	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00277	0.00277	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00257	0.00257	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Epirubicin—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Epirubicin—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
